Akoya Biosciences, Inc.: accounts_receivable
| Value | {"amount": 9729000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | current |
| Entity | Akoya Biosciences, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:31:37.353259+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6ef3ac76-bfb0-4708-af70-0c8fa7ff2484
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-23-002954Retrieved: 2026-08-19T17:31:37.353259+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001711933/accounts-receivable/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6ef3ac76-bfb0-4708-af70-0c8fa7ff2484
History
- no predecessors — first report